PGP and Stroke: In the future, we will evaluate the efficacy of PgP as a therapeutic gene delivery carrier in preclinical animal models of SCI, traumatic brain injury, stroke, and other neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s diseases, Huntington’s Diseases, and Amyotrophic Lateral Sclerosis.